For research use only. Not for therapeutic Use.
BI-0474（Cat No.:I042632）is an investigational small molecule being developed for its potential therapeutic applications in cancer treatment. It functions by targeting specific molecular pathways involved in tumor cell proliferation, survival, and metastasis. By inhibiting these pathways, BI-0474 aims to disrupt the growth of cancer cells and enhance the effects of other therapies. Early preclinical studies have shown promising results in reducing tumor growth and overcoming resistance to conventional treatments. Ongoing research is focused on evaluating its safety, pharmacokinetics, and efficacy in clinical trials for various types of cancer.
| CAS Number | 2750570-55-7 |
| Synonyms | (4S)-2-amino-4-[3-[6-[(2S)-2,4-dimethylpiperazin-1-yl]-4-(4-prop-2-enoylpiperazin-1-yl)pyridin-2-yl]-1,2,4-oxadiazol-5-yl]-4-methyl-6,7-dihydro-5H-1-benzothiophene-3-carbonitrile |
| Molecular Formula | C30H37N9O2S |
| Purity | ≥95% |
| IUPAC Name | (4S)-2-amino-4-[3-[6-[(2S)-2,4-dimethylpiperazin-1-yl]-4-(4-prop-2-enoylpiperazin-1-yl)pyridin-2-yl]-1,2,4-oxadiazol-5-yl]-4-methyl-6,7-dihydro-5H-1-benzothiophene-3-carbonitrile |
| InChI | InChI=1S/C30H37N9O2S/c1-5-25(40)38-12-10-37(11-13-38)20-15-22(33-24(16-20)39-14-9-36(4)18-19(39)2)28-34-29(41-35-28)30(3)8-6-7-23-26(30)21(17-31)27(32)42-23/h5,15-16,19H,1,6-14,18,32H2,2-4H3/t19-,30-/m0/s1 |
| InChIKey | CKAMBYUZKWQCKJ-ADSBAMQRSA-N |
| SMILES | C[C@H]1CN(CCN1C2=CC(=CC(=N2)C3=NOC(=N3)[C@]4(CCCC5=C4C(=C(S5)N)C#N)C)N6CCN(CC6)C(=O)C=C)C |
